• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We're Reading: SCOTUS Asks for More Information in Contraception Case

Article

What we're reading, March 30, 2016: the Supreme Court asks for more information in birth control case; Americans display lack of knowledge about Zika virus; and China provides an opportunity for drugs that fail to make it to market elsewhere.

With only 8 sitting members on the Supreme Court, the judges appear deadlocked on an important case on contraception access. Kaiser Health News reported that the court has asked lawyers involved in the case to provide more information on how women working for religious employers may access birth control. The judges had seemed evenly divided after arguments last week, and the court is also asking the lawyers to provide a possible compromise in the case.

Although Americans recognize that the Zika virus is spreading and could reach the continental US, they are unaware of the basic facts of the virus. While a large majority of people realize the virus is spread by mosquitoes, one-third also believe Zika can be spread by coughing or sneezing, according to USA Today. In addition, nearly one-fourth of adults in households where someone is pregnant or considering becoming pregnant didn’t know about the link between Zika and microcephaly.

China is providing a second life for some drugs that don’t make it to market elsewhere in the world. Companies licensing drugs to Chinese startups after a treatment fails to outperform other drugs is becoming a new trend, reported The Wall Street Journal. However, it isn’t unusual or unlawful for companies to get a drug approved in one jurisdiction but not another, and in China companies don’t have to prove a drug’s superiority over existing treatments.

Related Videos
Eric Levin, Scripta
Margaret Krackeler, MD
Margaret Krackeler, MD
Margaret Krackeler, MD
A new study finds law enforcement presence in emergency departments may disrupt care. Lead author Prashasti Bhatnagar discusses policy and training solutions.
Jennifer Snow, MPA, NAMI
Jennifer Snow, MPA, NAMI
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.